K
Kazia Therapeutics Limited D
D
KZIA
7.15000
USD
0.56
(8.50%)
مغلق
حجم التداول
8,521
الربح لكل سهم
-40
العائد الربحي
-
P/E
-0
حجم السوق
9,721,319
الأخبار المقالات
العنوان: Kazia Therapeutics Limited
القطاع: Healthcare
الصناعة: Biotechnology
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.